Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Pedestrian Crash at McLaughlin Avenue and Story Road


Victim Killed in Fatal Hit and Run Accident in San Jose

San Jose, CA (March 16, 2020) – A man was killed in a pedestrian crash in San Jose. The fatal accident occurred on the evening of March 16 at McLaughlin Avenue and Story Road.

A man was crossing the intersection when he was hit by a car. Emergency crews found the man lying in the road. He died at the accident scene. The driver fled the crash site.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Jose

#95122


January 14, 2020

1 Killed in Crash on Bear Valley Road

2 Vehicles Involved in Fatal Apple Valley Accident...


April 27, 2020

Bicyclist Killed in Crash at Calle Real and Daffodil Lane

Bicycle Hit by Car in Fatal Goleta Accident...


November 12, 2019

Woman Killed in Pedestrian Crash on Floral Road

Jennifer Simonian Hits Victim in Fatal Selma Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.